Skip to content
akaturk Academic measurement
Search

Article detail · 2006 · article

Possible Problem With Optipen Pro 1 Should diabetic patients continue to use this product

Journal Diabetes Care
ISSN0149-5992
YÖKSİS OpenAlex
Year2006
Citations2OpenAlex
Citations2Semantic Scholar · 1 influential
Percentile%55.4
FWCI0.161.00 = world average
Scopus (SJR)Q1
WoS (JCR)Q1

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueDiabetes Care
  • Catalog match (ISSN)Diabetes Care
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

Insulin glargine is a modified basal insulin analog that has been recently introduced and is now available worldwide. Insulin glargine is available in 3-ml cartridges that can be used with the OptiPen Pro-1 (Sanofi-Aventis). The Medicines and Healthcare Products Regulatory Agency (MHRA; executive agency of the Department of Health in the U.K., which enhances and safeguards the health of the public by ensuring the effectiveness of medicines and medical devices) has received a significant number of reports concerning difficulties in the operation and use of the OptiPen Pro-1 insulin pen injection system. …

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

2citationsOpenAlex · cited_by_count (cache / database)

Authors

4
  1. RUHSAR DAMLA GÖKŞEN EGE ÜNİVERSİTESİ 1
  2. ŞÜKRAN DARCAN 2
  3. büyükinan muammer 3
  4. emine kurt 4